The U.S. Patent and Trademark Office has announced a revised agenda for the next biotechnology/ chemical/pharmaceutical (BCP) customer partnership meeting to be held on June 6, 2012. New to the agenda is an afternoon session on the Recommendation for the Disclosure of Sequence Listings using XML (Proposed ST.26). The time slots for a number of sessions have also been changed. The revised agenda is as follows:
Morning Session
• Opening Remarks (9:00 - 9:15 am ET): George Elliott, Wanda Walker, and Dan Sullivan (Acting), Directors, Technology Center 1600
• AIA Update (9:15 - 10:15 am): Janet Gongola, Patent Reform Coordinator
• Break (10:15 - 10:30 am)
• Cooperative Patent Classification Overview (10:30 - 11:15 am): Bruce Kisliuk, Deputy Commissioner for Patent Administration
• Claim Interpretation (11:15 am - 12:00 pm): Jeffrey Lundgren, SPE, Art Unit 1629
• Lunch (12:00 – 1:15 pm)
Afternoon Session
• Mayo v. Prometheus (1:15 - 2:45 pm): Roberte Makowski, Connolly Bove Lodge & Hutz, LLP,
and Hans Sauer, Associate General Counsel for BIO
• Break (2:45 - 3:00 pm)
• Recommendation for the Disclosure of Sequence Listings using XML (Proposed ST.26) (3:00 - 3:30 pm): Susan Wolski, PCT Legal
• Range Limitations in Claims (3:30 - 4:15 pm): Jean Witz, QAS, TC1600
• Closing Remarks/Discussion (4:15 - 4:30 pm): George Elliott, Wanda Walker, and Dan Sullivan (Acting), Directors, Technology Center 1600
The meeting can be attended in person at the USPTO's Madison Auditorium, 600 Dulany Street, Alexandria, VA, or viewed online here (click "Join Now"). Individuals wishing to join the teleconference only should call +1-408-600-3600 (U.S./Canada, toil number), and use the access code: 991 681 937. Those wishing to attend the meeting should contact Cecilia Tsang by phone at 571-272-0562, by fax at 571-273-0562, or by e-mail at [email protected] by June 4, 2012 to confirm their attendance. Additional information regarding the BCP customer partnership meeting can be found here.
Comments